Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges

被引：8
作者：
Ravi, Praful [1 ]
Whelpley, Bridget [1 ]
Kelly, Emma [1 ]
Wolanski, Andrew [1 ,2 ]
Ritzer, Jolivette [1 ,2 ]
Robertson, Matthew [1 ,2 ]
Shah, Hina [1 ,2 ]
Morgans, Alicia K. [1 ]
Wei, Xiao X. [1 ]
Sunkara, Rajitha [1 ]
Pomerantz, Mark [1 ]
Taplin, Mary -Ellen [1 ]
Kilbridge, Kerry L. [1 ]
Choudhury, Atish D. [1 ]
Jacene, Heather [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 03期
关键词：
RESISTANT PROSTATE-CANCER; MULTICENTER; THERAPY;
D O I：
10.2967/jnumed.122.265194
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：349 / 350
页数：2
相关论文
共 45 条
  • [41] Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
    Jackson, Price A.
    Hofman, Michael S.
    Hicks, Rodney J.
    Scalzo, Mark
    Violet, John
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (07) : 1030 - 1036
  • [42] Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy
    Khreish, Fadi
    Wiessner, Mona
    Rosar, Florian
    Ghazal, Zaidoon
    Sabet, Amir
    Maus, Stephan
    Linxweiler, Johannes
    Bartholomae, Mark
    Ezziddin, Samer
    BIOMOLECULES, 2021, 11 (08)
  • [43] 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
    Morris, Michael J.
    Castellano, Daniel
    Herrmann, Ken
    de Bono, Johann S.
    Shore, Neal D.
    Chi, Kim N.
    Crosby, Michael
    Piulats, Josep M.
    Flechon, Aude
    Wei, Xiao X.
    Mahammedi, Hakim
    Roubaud, Guilhem
    Studentova, Hana
    Nagarajah, James
    Mellado, Begona
    Montesa-Pino, Alvaro
    Kpamegan, Euloge
    Ghebremariam, Samson
    Kreisl, Teri N.
    Wilke, Celine
    Lehnhoff, Katja
    Sartor, Oliver
    Fizazi, Karim
    LANCET, 2024, 404 (10459) : 1227 - 1239
  • [44] Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings
    Cicali, Emily J.
    Weitzel, Kristin Wiisanen
    Elsey, Amanda R.
    Orlando, Frank A.
    Vinson, Michelle
    Mosley, Scott
    Smith, D. Max
    Davis, Richard
    Drum, Lori
    Estores, David
    Franciosi, James P.
    Hagen, Melanie Gross
    Jerkins, Gabriel J.
    Mercado, Elvira S.
    Nainaparampil, Jaison
    Padron, Adaixa
    Rosenberg, Eric I.
    Wright, Ashleigh
    Schmidt, Siegfried O.
    Mathews, Carol A.
    Cavallari, Larisa H.
    Johnson, Julie A.
    GENETICS IN MEDICINE, 2019, 21 (10) : 2264 - 2274
  • [45] Portal Venous Tumor Thrombosis and Visceral Organ Metastasis without Skeletal Involvement in mCRPC: Adverse Prognostic Indicators on Dual Tracer PET/CT and Clinical Outcome after 177 Lu-PSMA-617 PRLT and Cabazitaxel Therapy
    Edamadaka, Yeshwanth
    Parghane, Rahul V.
    Basu, Sandip
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (04) : 302 - 306
12345